Thus, MOPDII is the second Mendelian disorder that predisposes to early onset atherosclerosis by augmenting SMC cytosolic stress, activating downstream HSF1/HMGCR/PERK signaling, and increasing SMC migration and atherosclerosis-associated phenotypic modulation. This evidence concerns the gene EIF2AK3 and atherosclerosis.